Management strategies for recurrent vasovagal syncope

Internal Medicine Journal

Volumn 40, Issue 8, 2010, Pages 554-560

  Vaddadi, G ^a   Corcoran, S J ^a   Esler, M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

hypotension; sympathetic nervous system; syncope; vasovagal

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; DIHYDROERGOTAMINE; FLUDROCORTISONE; MIDODRINE; MINERALOCORTICOID; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AGE DISTRIBUTION; CLINICAL TRIAL; COUNTERPULSATION; DIET; FLUID INTAKE; HEADACHE; HEART PACING; HEMODYNAMICS; HUMAN; HYDRATION; HYPERTENSION; HYPOKALEMIA; LOW DRUG DOSE; MORBIDITY; NAUSEA; PATIENT EDUCATION; PERIPHERAL EDEMA; PRIORITY JOURNAL; REFLEX; REVIEW; SIDE EFFECT; SLEEP DISORDER; STANDING; SYNCOPE; SYSTOLIC BLOOD PRESSURE; URINARY FREQUENCY;

ANIMALS; DISEASE MANAGEMENT; FLUDROCORTISONE; HUMANS; PATIENT EDUCATION AS TOPIC; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SYNCOPE, VASOVAGAL;

EID: 77955780863     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02295.x     Document Type: Review

References (30)

1. Vaddadi G, Lambert E, Corcoran SJ, Esler MD. Postural syncope: mechanisms and management. Med J Aust 2007 187 : 299 304.
2. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 2006 17 : 1172 6.
3. Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol 2005 95 : 668 71.
4. Vaddadi G, Esler MD, Dawood T, Lambert E. Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J 2010 doi: 10.1093/eurheartj/ehq071.
5. Santhouse J, Carrier C, Arya S, Fowler H, Duncan SA. Comparison of self-reported quality of life between patients with epilepsy and neurocardiogenic syncope. Epilepsia 2007 48 : 1019 22.
6. Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Thomsen PE et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J 2004 25 : 2054 72.
7. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M. Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 2006 27 : 344 50.
8. Nowak L, Nowak FG, Janko S, Dorwarth U, Hoffmann E, Botzenhardt F. Investigation of various types of neurocardiogenic response to head-up tilting by extended hemodynamic and neurohumoral monitoring. Pacing Clin Electrophysiol 2007 30 : 623 30.
9. McGavigan AD, Hood S. The influence of sex and age on response to head-up tilt-table testing in patients with recurrent syncope. Age Ageing 2001 30 : 295 8.
10. Vaddadi G, Lambert E, Guo L, Eikelis N, Socratous F, Schlaich M et al. Abstract 816: sympathetic nerve protein analysis, sympathetic microneurography and catecholamine kinetics in postural syncope phenotypes. Circulation 2007 116 : II158.
11. Vaddadi G, Lambert E, Guo L, Eikelis N, Socratous F, Jennings GL et al. Sympathetic neurobiology of orthostatic intolerance: a systematic biochemical and molecular analysis of patients with vasovagal syncope, low supine systolic blood pressure and postural tachycardia syndrome. Heart Lung Circ 2008 17 : S2.
12. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE et al. Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncope. Europace 2001 3 : 253 60.
13. Shen WK, Decker WW, Smars PA, Goyal DG, Walker AE, Hodge DO et al. Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation 2004 110 : 3636 45.
14. Giada F, Silvestri I, Rossillo A, Nicotera PG, Manzillo GF, Raviele A. Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncope. Europace 2005 7 : 465 71.
15. van Dijk N, Boer MC, De Santo T, Grovale N, Aerts AJ, Boersma L et al. Daily, weekly, monthly, and seasonal patterns in the occurrence of vasovagal syncope in an older population. Europace 2007 9 : 823 8.
16. Olde Nordkamp LR, Wieling W, Zwinderman AH, Wilde AA, van Dijk N. Genetic aspects of vasovagal syncope: a systematic review of current evidence. Europace 2009 11 : 414 20.
17. Claydon VE, Schroeder C, Norcliffe LJ, Jordan J, Hainsworth R. Water drinking improves orthostatic tolerance in patients with posturally related syncope. Clin Sci (Lond) 2006 110 : 343 52.
18. Raj SR, Rose S, Ritchie D, Sheldon RS. The Second Prevention of Syncope Trial (POST II) - a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 2006 151 : 1186 e11 17.
19. Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006 113 : 1164 70.
20. Liao Y, Li X, Zhang Y, Chen S, Tang C, Du J. alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data. Acta Paediatr 2009 98 : 1194 200.
21. Olver IN, Jennings GL, Bobik A, Esler M. Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. Br Med J 1980 281 : 275 6.
22. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999 33 : 1227 30.
23. Brignole M, Menozzi C, Del Rosso A, Costa S, Gaggioli G, Bottoni N et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace 2000 2 : 66 76.
24. Sheldon R, Connolly S. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials. Card Electrophysiol Rev 2003 7 : 411 15.
25. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004 25 : 1741 8.
26. Brignole M. International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design. Europace 2007 9 : 25 30.
27. Tan MP, Parry SW. Vasovagal syncope in the older patient. J Am Coll Cardiol 2008 51 : 599 606.
28. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med 1985 55 : 45 54.
29. Parry SW, Steen N, Bexton RS, Tynan M, Kenny RA. Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: a randomised, double-blind, placebo controlled crossover trial. Heart 2009 95 : 405 9.
30. Mendu ML, McAvay G, Lampert R, Stoehr J, Tinetti ME. Yield of diagnostic tests in evaluating syncopal episodes in older patients. Arch Intern Med 2009 169 : 1299 305.